This study is not yet accepting patients

LTFU for All Cell and Gene Therapy Studies

a study on Hepatocellular Cancer Liver Cancer Prostate Cancer

Summary

Eligibility
for people ages 18-130 (full criteria)
Location
at Orange, California and other locations
Dates
study started
study ends around
Principal Investigator
by Farshid Dayyani

Description

Summary

Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.

Official Title

A LOng-term Follow-up Master Protocol for Participants Who Received Cell or Gene Therapies in Other AstraZeneca StUdieS (LOCUS)

Details

This is a multi-centre and multinational basket study that will monitor the long-term safety and tolerability of cell or gene therapies in participants that have taken part in other AstraZeneca cell or gene therapy studies for up to 15 years.

Keywords

Hepatocellular Carcinoma, Prostate Cancer, Cell Therapy, Gene Therapy, Long term follow up, LTFU, Prostatic Neoplasms, AZD5851, AZD0754

Eligibility

You can join if…

Open to people ages 18-130

  1. The participant has received a cell or gene therapy in another AstraZeneca protocol.
  2. Provision of signed and dated, written informed consent before any study-specific procedures.

You CAN'T join if...

Not applicable

-

Locations

  • Research Site
    Orange California 92868 United States
  • Research Site
    Duarte California 91010 United States

Lead Scientist at UC Irvine

  • Farshid Dayyani
    Clinical Professor, Medicine, School of Medicine. Authored (or co-authored) 134 research publications

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
AstraZeneca
ID
NCT06194461
Study Type
Observational
Participants
Expecting 64 study participants
Last Updated